¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Brachial plexus disorders"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • plexus pancreaticus ³ª
    ÃéÀå½Å°æ¾ó±â, Ãé½Å°æÃÑ(õýãêÌèõ¿).
  • plexus papilloma
    ¸Æ¶ôÃÑÀ¯µÎÁ¾(ØæÕ©õ¿êáÔéðþ).
  • plexus papilloma
    ¸Æ¶ôÃÑÀ¯µÎÁ¾(ØæÕ©õ¿êáÔéðþ)
  • plexus parotideus ³ª
    ±Í¹Ø»ù½Å°æ¾ó±â, ÀÌÇϼ±½Å°æÃÑ(ì¼ù»àÍãêÌèõ¿).
  • plexus parotideus ³ª
    Í£Áû³ïº·w¾ó±â, ÀÌÇϼ±½Å°æÃÑ(ì¼ù»àÍãêÌèõ¿).
  • plexus pelvinus ³ª
    °ñ¹Ý½Å°æ¾ó±â, °ñ¹Ý½Å°æÃÑ(ÍéÚïãêÌèõ¿).
  • plexus periarterialis ³ª
    µ¿¸ÆÁÖÀ§½Å°æ¾ó±â, µ¿¸ÆÁÖÀ§½Å°æÃÑ(ÔÑØæñ²êÌãêÌèõ¿ ).
  • plexus pharyngeus ³ª
    ÀεÎÁ¤¸Æ¾ó±â, ÀενŰæ¾ó±â, ÀεÎÁ¤¸ÆÃÑ(ìÖÔéð¡Øæõ¿), ÀενŰæÃÑ.
  • plexus pharyngooesophagicus dorsalis ³ª
    µîÂÊÀενĵµÁ¤¸Æ, ÈÄÀενĵµÁ¤¸Æ ÃÑ(ý­ìÖÔéãÝÔ³ð¡Øæõ¿).
  • plexus pharyngooesophagicus ventralis ³ª
    ¹èÂÊÀενĵµÁ¤¸Æ¾ó±â, ÀüÀÎµÎ½Ä µµÁ¤¸ÆÃÑ(îñìÖÔéãÝÔ³ð¡Øæõ¿).
  • plexus phrenicus ³ª
    Ⱦ°Ý¸·½Å°æ¾ó±â, Ⱦ°Ý½Å°æÃÑ(üô̰ãêÌèõ¿).
  • plexus popliteus ³ª
    ¿À±Ý¾ó±â, ½½¿ÍÃÑ (ã£èÀõ¿).
  • plexus prostaticus ³ª
    Àü¸³»ù½Å°æ¾ó±â, Àü¸³¼±½Å°æÃÑ(îñí¡àÍãêÌèõ¿).
  • plexus pterygoideus ³ª
    ³¯°³µ¹±â¾ó±â, À͵¹±âÃÑ(ìÏÔÍÑÃõ¿).
  • plexus pudendalis ³ª
    À½ºÎ½Å°æ¾ó±â, À½ºÎÁ¤¸Æ¾ó±â, À½ºÎ½Å°æÃÑ(ëäÝ»ãêÌèõ¿), À½ºÎÁ¤¸ÆÃÑ(ëäÝ»ð¡Øæõ¿).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • tobacco-related disorders
    Åä¹ÙÄÚ(´ã¹è)°ü·ÃÀå¾Ö(~º´).
  • topographic localization disorders
  • voice disorders, organic
    ±âÁú(Àû) À½¼ºÀå¾Ö
  • voice disorders, psychogenic
    ½ÉÀÎ(¼º) À½¼ºÀå¾Ö
  • x linked disorders
    X¿¬°ü(XÀÇÁ¸)Àå¾Ö, X¿¬°üÁúº´
  • abdominal aortic plexus
    ¹è´ëµ¿¸Æ½Å°æ¾ó±â
  • anterior external vertebral venous plexus
    ¾Õ¹Ù±ùôÁÖÁ¤¸Æ¾ó±â
  • anterior internal vertebral venous plexus
    ¾Õ¼ÓôÁÖÁ¤¸Æ¾ó±â
  • areolar venous plexus
    Á¥²ÉÆÇÁ¤¸Æ¾ó±â
  • arterial plexus
    µ¿¸ÆÃÑ
  • auerbachs plexus
    ¾Æ¿ì¹ÙÈå¾ó±â, ÃÑ(õ¿)
  • autonomic nerve plexus
    ÀÚÀ²½Å°æ¾ó±â
  • autonomic plexus
    ÀÚÀ²½Å°æ¾ó±â
  • axillary lymphatic plexus
    °Üµå¶û¸²ÇÁ°ü¾ó±â
  • azygous thyroid plexus
    Ȧ°©»óÁ¤¸Æ¾ó±â
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • Dermal nerve plexus
    ÁøÇǽŰæ¾ó±â
    [¿¾ ¿ë¾î] ÁøÇǽŰæÃÑ
  • Vaginal venous plexus
    ÁúÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] ÁúÁ¤¸ÆÃÑ
  • Plexus of spinal nerves
    ô¼ö½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ô¼ö½Å°æÃÑ
  • Vertebral plexus
    ôÃ߽Űæ¾ó±â
    [¿¾ ¿ë¾î] Ãß°ñµ¿¸Æ½Å°æÃÑ
  • Cavernous plexus of concha
    ÄÚ¼±¹ÝÇØ¸é¾ó±â
    [¿¾ ¿ë¾î] ºñ°©°³ÇظéÃÑ
  • Cavernous plexus of nasal concha
    ÄÚ¼±¹ÝÇØ¸é¾ó±â
    [¿¾ ¿ë¾î] ºñ°©°³ÇظéÃÑ
  • Renal plexus
    ÄáÆÏ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ½Å½Å°æÃÑ
  • Venous plexus of foramen ovale
    Ÿ¿ø±¸¸ÛÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] ³­¿ø°øÁ¤¸ÆÃÑ
  • Subepidermal nerve plexus
    Ç¥ÇǹؽŰæ¾ó±â
    [¿¾ ¿ë¾î] Ç¥ÇÇÇϽŰæÃÑ
  • Subcutaneous lymphatic plexus
    ÇǺιظ²ÇÁ°ü¾ó±â
    [¿¾ ¿ë¾î] ÇÇÇÏÀӯİüÃÑ
  • Subcutaneous nerve plexus
    ÇǺιؽŰæ¾ó±â (¢Ñ ½Å°æÁ¾¸»)¡¡
    [¿¾ ¿ë¾î] ÇÇÇϽŰæÃÑ
  • Subcutaneous venous plexus
    ÇǺιØÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] ÇÇÇÏÁ¤¸ÆÃÑ
  • Lumbar plexus
    Ç㸮½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ¿ä½Å°æÃÑ
  • Lumbosacral plexus
    Ç㸮¾ûÄ¡½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ¿äõ°ñ½Å°æÃÑ
  • Pulmonary plexus
    ÇãÆÄ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] Æó½Å°æÃÑ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
ASDC American Society of Dentistry for Children; Association of Sleep Disorders Centers
AUDIT alcohol use disorders identification test
CAMDEX Cambridge mental disorders of the elderly examination
CELDIC Commission on Emotional and Learning Disorders in Children
DDRT diseases, disorders and related topics
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
PT-LPDs Post-transplantation lymphoproliferative disorders
PRIME-MD Primary Care Evaluation of Mental Disorders
SADS-L Schedule for Affective Disorders and Schizophrenia Lifetime Version
SRBD Sleep-Related Breathing Disorders
SCID II Structured Clinical Interview for DSM-III-R Personality Disorders
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
social behaviour disorders Behaviours which are at variance with the expected social norm and which affect other individuals.
(12 Dec 1998)
somatoform disorders Disorders having the presence of physical symptoms that suggest a general medical condition and that are not fully explained by a general medical condition, by the direct effects of a substance, or by another mental disorder. The symptoms must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to factitious disorders and malingering, the physical symptoms are not under voluntary control.
(12 Dec 1998)
speech disorders Long-term disorders in speaking or in perception of speech.
(12 Dec 1998)
necrobiotic disorders A group of disorders characterised by swelling, basophilia, and distortion of collagen bundles in the dermis.
(12 Dec 1998)
neurotic disorders Disorders in which the symptoms are distressing to the individual and recognised by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
(12 Dec 1998)
stress disorders, posttraumatic Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event and numbing of responsiveness to or reduced involvement with the external world.
(12 Dec 1998)
substance abuse disorders A class of mental disorders in which behavioural and biological changes are associated with regular use of alcohol, drugs, and related substances that affect the central nervous system and personal and social functioning.
(05 Mar 2000)
substance-induced organic mental disorders Mental disorders caused by use of drugs, e.g., cocaine.
(05 Mar 2000)
substance-related disorders These non-psychotic disorders include those related to the taking of a drug of abuse (including alcohol), to the side effects of a medication, and to toxin exposure.
(12 Dec 1998)
delirium, dementia, amnestic, cognitive disorders Cognitive disorders including delirium, dementia, and other cognitive disorders. These may be the result of substance use, trauma, or other causes.
(12 Dec 1998)
disorders, myeloproliferative Tumours of certain bone marrow cells including those that give rise to red cells, granulocytes, and platelets. As opposed to the lymphoproliferative disorders.
(12 Dec 1998)
dissociative disorders Sudden temporary alterations in the normally integrative functions of consciousness.
(12 Dec 1998)
immunodeficiency disorders <radiology> B-cell (antibody) deficiency: high-grade pathogens: pneumococcus, strep, H. Flu, chronic sinopulmonary disease, usual survival to adulthood, T-cell (cellular) deficiency: low-grade pathogens: fungi, viruses, Pneumocystic, growth retardation, diarrhoea, delayed anergy, short life-span, susceptible to graft vs. Host (GvH) disease, e.g.: DiGeorge syndrome, Nezelhof syndrome Note: increased risk of malignancy
(12 Dec 1998)
immunoproliferative disorders Disorders characterised by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins.
(12 Dec 1998)
impulse control disorders Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á